Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a routine version update to the page rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T21:54:27.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This indicates a small update to the page's version metadata, with no changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:28:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Expanded the study record with additional sections and documents, including the study protocol and statistical analysis plan PDF, sponsor/collaborator details, and updated dates and outcome measures. These additions provide deeper context about the trial's design, interventions, and results timeline.
    Difference
    47%
    Check dated 2026-08-01T20:03:35.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.6.4 added. A broad set of institutional names, document references, and related metadata were removed from the study record, indicating metadata cleanup rather than changes to the study design or eligibility.
    Difference
    17%
    Check dated 2026-07-25T17:44:47.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision label changed from v3.6.2 to v3.6.3, indicating a minor version update to the page. This update is administrative and does not alter the page's substantive information.
    Difference
    0.1%
    Check dated 2026-07-04T13:18:47.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2. This appears to be a minor metadata update with no substantive changes to the study information or page content.
    Difference
    0.1%
    Check dated 2026-06-27T06:37:20.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.